2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
2019 ESC Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD
Publications
3 shownDapagliflozin in Patients with Chronic Kidney Disease
Among patients with chronic kidney disease, regardless of the presence or absence of diabetes, the risk of a composite of a sustained decline in the estimated GFR of at least 50...
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a med...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 4
- Citations
- 19,336
- Institution
- University College London
External Links
Identifiers
- ORCID
- 0000-0003-0745-3478
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.